
THC reference
17.3–21.2%
Population reference · not measured for Freakshow IBL
CBD
≥4%
Catalog-reported value · not a batch result
About these reference ranges
Reference ranges show the middle half of historical flower lab medians across many named samples. They are context for missing data, not an estimate of this cultivar or a batch result. Check the product's lab report for potency.
CBD-rich cultivars and individual batches can fall far outside these historical reference ranges.
THC reference 17.3–21.2%: 1,800 flower readings across 278 name groups (2015–2019); Analytical360, PSI Labs, SC Labs.
Freakshow IBL is a hybrid cannabis strain by 7 East Genetics with up to 35% THC. Known for its balanced effects combining body relaxation and mental uplift.
Where to buy Freakshow IBL seeds ↓No effect, terpene, flavor or medical-use data specific to Freakshow IBL has been published yet, so we don't guess. For what hybrid strains usually do, see the effects guide.
Are you a cultivar breeder or genetics company?
Do you breed Freakshow IBL? Discuss your catalog and profile with StrainCompass. Verification requires an ownership review.
About Freakshow IBL
Freakshow IBL, a hybrid crafted by 7 East Genetics with a whopping 35% THC and 6% CBD, is a potent pick for experienced users craving creative, euphoric, happy, and relaxed vibes that spark inspiration. Its dominant terpenes—caryophyllene, myrcene, and limonene—lend an earthy, herbal, and sweet flavor that adds a layer of enjoyment to its effects. This strain stands out for its high potency and versatility in addressing anxiety, depression, pain, and stress, making it a favorite for those who want a strong, multifaceted high.
Where to Buy Seeds
Independent partner links. StrainCompass is an educational directory and does not sell or ship physical goods. We may earn an affiliate commission from qualifying third-party purchases.
Frequently Asked Questions about Freakshow IBL
Is Freakshow IBL an Indica, Sativa, or Hybrid?
Freakshow IBL is classified as a hybrid cannabis strain.